RETRACTED: miR-122 Regulates Tumorigenesis in Hepatocellular Carcinoma by Targeting AKT3 (Retracted article. See vol. 12, art no e0184778, 2017)

被引:71
|
作者
Nassirpour, Rounak [1 ]
Mehta, Pramod P. [1 ]
Yin, Min-Jean [1 ]
机构
[1] Pfizer Worldwide Res & Dev, Oncol Res, San Diego, CA USA
来源
PLOS ONE | 2013年 / 8卷 / 11期
关键词
HEPATITIS-C VIRUS; MICRORNA; EXPRESSION; GENOMICS; KINASE;
D O I
10.1371/journal.pone.0079655
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
MicroRNAs (miRNAs) have been implicated in the orchestration of diverse cellular processes including differentiation, proliferation, and apoptosis and are believed to play pivotal roles as oncogenes and tumor suppressors. miR-122, a liver specific miRNA, is significantly down-regulated in most hepatocellular carcinomas (HCCs) but its role in tumorigenesis remains poorly understood. Here we identify AKT3 as a novel and direct target of miR-122. Restoration of miR-122 expression in HCC cell lines decreases AKT3 levels, inhibits cell migration and proliferation, and induces apoptosis. These anti-tumor phenotypes can be rescued by reconstitution of AKT3 expression indicating the essential role of AKT3 in miR-122 mediated HCC transformation. In vivo, restoration of miR-122 completely inhibited xenograft growth of HCC tumor in mice. Our data strongly suggest that miR-122 is a tumor suppressor that targets AKT3 to regulate tumorigenesis in HCCs and a potential therapeutic candidate for liver cancer.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] RETRACTION: miR-122 Regulates Tumorigenesis in Hepatocellular Carcinoma by Targeting AKT3 (Retraction of Vol 8, art no E79655, 2013)
    Nassirpour, R.
    Mehta, P. P.
    Yin, M-J
    PLOS ONE, 2017, 12 (09):
  • [2] RETRACTED: MiR-122 Promotes the Development of Colon Cancer by Targeting ALDOA In Vitro (Retracted article. See vol. 22, 2023)
    Li, Hong
    Zhang, Xinhua
    Jin, Zhao
    Yin, Tao
    Duan, Chuanyi
    Sun, Junwei
    Xiong, Rui
    Li, Zilin
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2019, 18 : 1533033819871300
  • [3] RETRACTED: miR-221 Promotes Tumorigenesis in Human Triple Negative Breast Cancer Cells (Retracted article. See vol. 12, art no e0175869, 2017)
    Nassirpour, Rounak
    Mehta, Pramod P.
    Baxi, Sangita M.
    Yin, Min-Jean
    PLOS ONE, 2013, 8 (04):
  • [4] RETRACTED: Retracted: The Witness Set Constraint (Retracted article. See vol. 34, art no e2, 2017)
    Fortuny, Jordi
    JOURNAL OF SEMANTICS, 2017, 34 (02)
  • [5] RETRACTED: miR-222 regulates sorafenib resistance and enhance tumorigenicity in hepatocellular carcinoma (Retracted article. See vol. 59, 2021)
    Liu, Kai
    Liu, Songyang
    Zhang, Wei
    Ji, Bai
    Wang, Yingchao
    Liu, Yahui
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2014, 45 (04) : 1537 - 1546
  • [6] RETRACTED: Regulation of Tumorigenesis in Hepatocellular Carcinoma via the AKT3 Pathway in Cell Lines (Retracted Article)
    Xing, Mingxuan
    Xie, Xinwei
    Liu, Zhi
    Du, Xiaohong
    COMPUTATIONAL AND MATHEMATICAL METHODS IN MEDICINE, 2021, 2021
  • [7] RETRACTED: Downregulation of miR-196-5p Induced by Hypoxia Drives Tumorigenesis and Metastasis in Hepatocellular Carcinoma (Retracted article. See vol. 14, 2023)
    Zheng, Hao
    Bi, Feng-rui
    Yang, Yuan
    Hong, Yong-gang
    Ni, Jun-sheng
    Ma, Long
    Liu, Ming-hua
    Hao, Li-qiang
    Zhou, Wei-ping
    Song, Li-hua
    Yan, Hong-Li
    HORMONES & CANCER, 2019, 10 (4-6): : 177 - 189
  • [8] RETRACTED: SIRT1 promotes tumorigenesis of hepatocellular carcinoma through PI3K/PTEN/AKT signaling (Retracted article. See vol. 49, 2023)
    Wang, Hanning
    Liu, Hao
    Chen, Kaiyun
    Xiao, Jinfeng
    He, Ke
    Zhang, Jinqian
    Xiang, Guoan
    ONCOLOGY REPORTS, 2012, 28 (01) : 311 - 318
  • [9] RETRACTED: Ferroportin in the progression and prognosis of hepatocellular carcinoma (Retracted article. See vol. 20, 38, 2015)
    Wang, Qin
    Zhou, Jun
    Zhong, Dewu
    Wang, Qunwei
    Huang, Jiangsheng
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2013, 18
  • [10] RETRACTED: MiR-892a Promotes Hepatocellular Carcinoma Cells Proliferation and Invasion Through Targeting CD226 (Retracted article. See vol. 122, pg. 1970, 2021)
    Jia, Baoxing
    Tan, Ludong
    Jin, Zhe
    Jiao, Yan
    Fu, Yu
    Liu, Yahui
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2017, 118 (06) : 1489 - 1496